SCHEMBL5363068

SCHEMBL5363068

O=C1Nc2c(Br)cc(Br)cc2C1=Cc1cc2ccccc2nc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.51
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
MDM2 Q00987 2/20 0.36
NPC1 O15118 3/20 0.36
SIRT1 Q96EB6 2/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT3 Q9NTG7 1/20 0.35
ALOX5 P09917 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MEN1 O00255 2/20 0.35
RAB9A P51151 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAP3K7 O43318 1/20 0.34
TAB1 Q15750 1/20 0.34
GAA P10253 1/20 0.34
RAF1 P04049 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7136980 0.81 EGFR (0.46) GSK3BLMNAPKMNPC1KDM4E
SCHEMBL7137055 0.81 GSK3B (0.49) GSK3BLMNAPKMMDM2NPC1
SCHEMBL7134869 0.80 SIRT1 (0.43) MDM2NPC1SIRT1SIRT2SIRT3
SCHEMBL7140270 0.79 NTRK1 (0.41) SIRT1SIRT2SIRT3KDM4EALDH1A1
SCHEMBL5365774 0.78 IKBKB (0.41) NPC1ALDH1A1MEN1KMT2AMAPT
SCHEMBL7130494 0.76 CYP11B2 (0.38) LMNAMDM2SIRT1SIRT2KDM4E
SCHEMBL7135677 0.76 MDM2 (0.47) MDM2SIRT1SIRT2SIRT3
SCHEMBL7135671 0.75 SIRT1 (0.46) MDM2SIRT1SIRT2SIRT3ALDH1A1
SCHEMBL7139764 0.75 NPC1 (0.57) NPC1ALDH1A1MEN1KMT2AMAPT
SCHEMBL5362880 0.75 PLK4 (0.57) SIRT1SIRT2SIRT3ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK GSK3B 315/4885LMNA 4250/4885PKM 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.